Biblio

Export 2536 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
C. - H. Yun, Lee, H. - Y., Lee, S. Ku, Kim, H., Seo, H. Suk, Bang, S. Ae, Kim, S. Eun, Greve, D. N., Au, R., Shin, C., and Thomas, R. J., “Amyloid Burden in Obstructive Sleep Apnea.”, J Alzheimers Dis, vol. 59, no. 1, pp. 21-29, 2017.
G. Rolfseng Grøntvedt, Lauridsen, C., Berge, G., White, L. R., Salvesen, Ø., Bråthen, G., and Sando, S. Botne, “The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up.”, J Alzheimers Dis, vol. 74, no. 3, pp. 829-837, 2020.
G. Rolfseng Grøntvedt, Lauridsen, C., Berge, G., White, L. R., Salvesen, Ø., Bråthen, G., and Sando, S. Botne, “The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up.”, J Alzheimers Dis, vol. 74, no. 3, pp. 829-837, 2020.
T. Schirinzi, Di Lorenzo, F., Sancesario, G. Maria, Di Lazzaro, G., Ponzo, V., Pisani, A., Mercuri, N. Biagio, Koch, G., and Martorana, A., “Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 525-532, 2018.
T. Schirinzi, Di Lorenzo, F., Sancesario, G. Maria, Di Lazzaro, G., Ponzo, V., Pisani, A., Mercuri, N. Biagio, Koch, G., and Martorana, A., “Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 525-532, 2018.
S. - K. Herukka, Rummukainen, J., Ihalainen, J., Fraunberg, Mvon Und Zu, Koivisto, A. M., Nerg, O., Puli, L. K., Seppälä, T. T., Zetterberg, H., Pyykkö, O. T., Helisalmi, S., Tanila, H., Alafuzoff, I., Hiltunen, M., Rinne, J., Soininen, H., Jääskeläinen, J. E., and Leinonen, V., “Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.”, J Alzheimers Dis, 2015.
S. - K. Herukka, Rummukainen, J., Ihalainen, J., Fraunberg, Mvon Und Zu, Koivisto, A. M., Nerg, O., Puli, L. K., Seppälä, T. T., Zetterberg, H., Pyykkö, O. T., Helisalmi, S., Tanila, H., Alafuzoff, I., Hiltunen, M., Rinne, J., Soininen, H., Jääskeläinen, J. E., and Leinonen, V., “Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.”, J Alzheimers Dis, 2015.
D. D. Quintana, Garcia, J. A., Anantula, Y., Rellick, S. L., Engler-Chiurazzi, E. B., Sarkar, S. N., Brown, C. M., and Simpkins, J. W., “Amyloid-β Causes Mitochondrial Dysfunction via a Ca2+-Driven Upregulation of Oxidative Phosphorylation and Superoxide Production in Cerebrovascular Endothelial Cells.”, J Alzheimers Dis, vol. 75, no. 1, pp. 119-138, 2020.
D. D. Quintana, Garcia, J. A., Anantula, Y., Rellick, S. L., Engler-Chiurazzi, E. B., Sarkar, S. N., Brown, C. M., and Simpkins, J. W., “Amyloid-β Causes Mitochondrial Dysfunction via a Ca2+-Driven Upregulation of Oxidative Phosphorylation and Superoxide Production in Cerebrovascular Endothelial Cells.”, J Alzheimers Dis, vol. 75, no. 1, pp. 119-138, 2020.
A. V. Morozov, Kulikova, A. A., Astakhova, T. M., Mitkevich, V. A., Burnysheva, K. M., Adzhubei, A. A., Erokhov, P. A., Evgen'ev, M. B., Sharova, N. P., Karpov, V. L., and Makarov, A. A., “Amyloid-β Increases Activity of Proteasomes Capped with 19S and 11S Regulators.”, J Alzheimers Dis, vol. 54, no. 2, pp. 763-76, 2016.
N. Liu, Yu, Z., Xun, Y., Shu, P., Yue, Y., Yuan, S., Jiang, Y., Huang, Z., Yang, X., Feng, X., Xiang, S., and Wang, X., “Amyloid-β25-35 Upregulates Endogenous Neuroprotectant Neuroglobin via NFκB Activation in vitro.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1163-1174, 2018.
M. Narukawa, Takahashi, S., Saito, T., Saido, T. C., and Misaka, T., “Analysis of Taste Sensitivities in App Knock-In Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 3, pp. 997-1004, 2020.
M. Narukawa, Takahashi, S., Saito, T., Saido, T. C., and Misaka, T., “Analysis of Taste Sensitivities in App Knock-In Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 3, pp. 997-1004, 2020.
B. K. Binukumar, Shukla, V., Amin, N. D., Bhaskar, M., Skuntz, S., Steiner, J., Winkler, D., Pelech, S. L., and Pant, H. C., “Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.”, J Alzheimers Dis, 2015.
B. K. Binukumar, Shukla, V., Amin, N. D., Bhaskar, M., Skuntz, S., Steiner, J., Winkler, D., Pelech, S. L., and Pant, H. C., “Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.”, J Alzheimers Dis, 2015.
B. K. Binukumar, Shukla, V., Amin, N. D., Bhaskar, M., Skuntz, S., Steiner, J., Winkler, D., Pelech, S. L., and Pant, H. C., “Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.”, J Alzheimers Dis, 2015.
S. Bagewadi Kawalia, Raschka, T., Naz, M., Simoes, Rde Matos, Senger, P., and Hofmann-Apitius, M., “Analytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1237-1254, 2017.
S. Bagewadi Kawalia, Raschka, T., Naz, M., Simoes, Rde Matos, Senger, P., and Hofmann-Apitius, M., “Analytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1237-1254, 2017.
H. - B. Kim, Park, B., and Shim, J. - Y., “Anemia in Association with Cognitive Impairment: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 72, no. 3, pp. 803-814, 2019.
C. Zhang, Zhang, Y., Shen, Y., Zhao, G., Xie, Z., and Dong, Y., “Anesthesia/Surgery Induces Cognitive Impairment in Female Alzheimer's Disease Transgenic Mice.”, J Alzheimers Dis, vol. 57, no. 2, pp. 505-518, 2017.
C. Birkenbihl, Westwood, S., Shi, L., Nevado-Holgado, A., Westman, E., Lovestone, S., and Hofmann-Apitius, M., “ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.”, J Alzheimers Dis, vol. 79, no. 1, pp. 423-431, 2021.
R. Fenoll, Pujol, J., Esteba-Castillo, S., de Sola, S., Ribas-Vidal, N., García-Alba, J., Sánchez-Benavides, G., Martínez-Vilavella, G., Deus, J., Dierssen, M., Novell-Alsina, R., and de la Torre, R., “Anomalous White Matter Structure and the Effect of Age in Down Syndrome Patients.”, J Alzheimers Dis, vol. 57, no. 1, pp. 61-70, 2017.
T. G. Beach, Maarouf, C. L., Intorcia, A., Sue, L. I., Serrano, G. E., Lu, M., Joshi, A., Pontecorvo, M. J., and Roher, A. E., “Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1509-1516, 2018.
T. G. Beach, Maarouf, C. L., Intorcia, A., Sue, L. I., Serrano, G. E., Lu, M., Joshi, A., Pontecorvo, M. J., and Roher, A. E., “Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1509-1516, 2018.
K. P. Kepp, Sensi, S. L., Johnsen, K. B., Barrio, J. R., Høilund-Carlsen, P. F., Neve, R. L., Alavi, A., Herrup, K., Perry, G., Robakis, N. K., Vissel, B., and Espay, A. J., “The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.”, J Alzheimers Dis, vol. 94, no. 2, pp. 497-507, 2023.

Pages